Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000475553 | SCV000551110 | pathogenic | Lynch syndrome | 2016-06-01 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 2-7 and the first 89 nucleotides of exon 8 of the MSH6 gene (c.261-3237_3735del). The 5' breakpoint of this deletion is within intron 1 at c.261-3237; the 3' breakpoint is within exon 8 at c.3735. This creates a premature translational stop signal and is expected to result in an absent or disrupted protein product. While this particular variant has not been reported in the literature, truncating variants in MSH6 are known to be pathogenic (PMID: 24362816, 18269114). For these reasons, this variant has been classified as Pathogenic. |